首页> 外文期刊>journal of isfahan medical school >Cotimparave evaluation of oral alprazolam, as premedication, on controlling blood pressure in hypertensive patients during surgery
【24h】

Cotimparave evaluation of oral alprazolam, as premedication, on controlling blood pressure in hypertensive patients during surgery

机译:口服阿普唑仑作为术前用药对控制高血压患者血压的 Cotimparave 评估

获取原文

摘要

© 2015, Isfahan University of Medical Sciences(IUMS). All rights reserved.Background: One of the major challenges in adult surgery is hypertension. Hypertensive patient are in danger of myocardial ischemia, increasing blood pressure in recovery room, kidney injury and cerebral artery damage. Regarding the previously reported positive effect of alprazolam in decreasing this complication, we decided to evaluate its efficacy in hypertensive patients undergoing surgery under general anesthesia. Methods: The present randomized controlled trial was conducted in 2014 in Alzahra Hospital, Isfahan, Iran. Study subjects (age range between 54 and 76 years) were candidates for elective surgery under general anesthesia. Patients were randomly divided into 2 groups, intervention and control. Control group received no drug and intervention group received alprazolam tablet (0.5 mg) before the surgery. Systolic and diastolic blood pressure, heart rate, respiratory rate, pulse oximetere, and O2 saturation during the surgery and pain severity, extubation time, recovery time and the dose of analgesic drugs after the surgery were evaluated and compared between the groups. Findings: Increasing blood pressure in the first 40 minutes of surgery (P = 0.001), pain severity (P = 0.012) and the dose of analgesic drugs (P = 0.001) were significantly less in intervention group compared to the control group. Conclusion: According to our results, alprazolam has an optimal efficacy in controlling blood pressure in hypertensive patients undergoing surgery and reducing pain severity in recovery room. In the absence of contraindications, it could be used as a prophylactic treatment in this group of patients.
机译:© 2015,伊斯法罕医科大学(IUMS)保留所有权利。背景:成人手术的主要挑战之一是高血压。高血压患者有心肌缺血、恢复室血压升高、肾损伤和脑动脉损伤的危险。关于先前报道的阿普唑仑在减少这种并发症方面的积极作用,我们决定评估其在全身麻醉下接受手术的高血压患者中的疗效。方法:本随机对照试验于 2014 年在伊朗伊斯法罕 Alzahra 医院进行。研究对象(年龄范围在 54 至 76 岁之间)是在全身麻醉下进行择期手术的候选人。患者被随机分为干预组和对照组 2 组。对照组不服用任何药物,干预组在手术前接受阿普唑仑片剂(0.5 mg)。评估比较两组手术时收缩压、舒张压、心率、呼吸频率、脉搏血氧仪、O2饱和度及术后疼痛严重程度、拔管时间、恢复时间、镇痛药物剂量。结果:与对照组相比,干预组手术前 40 分钟内血压升高 (P = 0.001)、疼痛严重程度 (P = 0.012) 和镇痛药物剂量 (P = 0.001) 显着减少。结论:研究结果显示,阿普唑仑在控制高血压患者手术血压和减轻恢复室疼痛严重程度方面效果最佳。在没有禁忌症的情况下,它可以用作这组患者的预防性治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号